You are here

Pharmaceutical Approval Update July 2007

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Two new agents—temsirolimus (Torisel) and estradiol (Divigel)—have been approved: temsirolimus for patients with advanced kidney cancer and estradiol for hot flashes associated with menopause. The newest indication for somatropin (rDNA origin) (Norditropin), approved as an injection for treating short stature in children with Noonan’s syndrome, is also discussed.